FilingReader Intelligence

Tiantan Bio approves donations and revises donation management

July 1, 2025 at 06:15 AM UTCBy FilingReader AI

Beijing Tiantan Biological Products Corp (SSE:600161) announced the resolutions passed at its Ninth Board's twenty-second meeting, held on June 30, 2025, via correspondence. The board unanimously approved revisions to the company's "External Donation Management Methods." Furthermore, the board approved two donation initiatives. The company's subsidiary, Sinopharm Group Lanzhou Biopharmaceutical Co., Ltd., will donate CNY 800,000 to the Gansu Provincial Health and Health Development Foundation. Additionally, Nanbu County Rongheng Single Plasma Collection Co., Ltd., another subsidiary, will donate CNY 30,000 to the Nanbu County Red Cross. The announcement confirms that all directors guarantee the accuracy and completeness of the disclosed information.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Beijing Tiantan Biological Products Corp publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →